- 全部删除
您的购物车当前为空
Remetinostat (SHP-141) 是一种基于异羟肟酸的组蛋白脱乙酰酶抑制剂,可用于治疗皮肤 T 细胞淋巴瘤的研究。

Remetinostat (SHP-141) 是一种基于异羟肟酸的组蛋白脱乙酰酶抑制剂,可用于治疗皮肤 T 细胞淋巴瘤的研究。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 1 mg | ¥ 119 | 待询 | |
| 5 mg | ¥ 278 | 待询 | |
| 10 mg | ¥ 445 | 待询 | |
| 25 mg | ¥ 889 | 待询 | |
| 50 mg | ¥ 1,370 | 待询 | |
| 100 mg | ¥ 2,260 | 待询 | |
| 200 mg | ¥ 3,170 | 待询 | |
| 1 mL x 10 mM (in DMSO) | ¥ 202 | In stock |
Remetinostat 相关产品
| 产品描述 | Remetinostat (SHP-141), a hydroxamic acid-based inhibitor of histone deacetylase enzymes, is currently being developed for the treatment of cutaneous T-cell lymphoma. |
| 别名 | SHP-141 |
| 分子量 | 323.34 |
| 分子式 | C16H21NO6 |
| CAS No. | 946150-57-8 |
| Smiles | O(C(CCCCCCC(NO)=O)=O)C1=CC=C(C(OC)=O)C=C1 |
| 密度 | no data available |
| 颜色 | White |
| 物理性状 | solid |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| 溶解度信息 | DMSO: 150 mg/mL (463.91 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
溶液配制表 | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||
评论内容